Coronary Artery Bypass Grafting

Comprehensive guide to CABG surgery — indications, procedure types, cost comparison, recovery, and risks. Connect with Gaf Healthcare to plan your bypass surgery.

Estimated cost: $4,500 – $8,000 · Average stay: 8–10 days

Coronary Artery Bypass Grafting (CABG), commonly referred to as bypass surgery or open-heart surgery, is one of the most frequently performed and extensively studied cardiac surgical procedures in the world. It is the definitive treatment for severe coronary artery disease — a condition where atherosclerotic plaque progressively narrows the coronary arteries that supply oxygenated blood to the heart muscle, ultimately threatening its function and the patient's life. CABG restores adequate blood flow to the heart by creating new pathways — "bypasses" — that route blood around the blocked sections of the coronary arteries, delivering oxygen directly to the heart muscle.

The procedure is performed by a cardiac surgeon working on a temporarily stopped heart, supported by a cardiopulmonary bypass (heart-lung) machine that takes over the functions of oxygenating blood and circulating it throughout the body during the operation. The surgeon harvests healthy blood vessels — grafts — from other parts of the body, most commonly the internal mammary artery from the chest wall, the radial artery from the forearm, and the saphenous vein from the leg, and uses them to create the bypass channels around blocked coronary arteries.

Despite the dramatic growth of interventional cardiology (angioplasty and stenting), CABG remains the preferred revascularization strategy for specific patient populations: those with three-vessel coronary artery disease, left main coronary artery stenosis, reduced heart function with multi-vessel disease, and diabetic patients with complex coronary anatomy. Long-term landmark trials, including the SYNTAX, FREEDOM, and EXCEL trials, have conclusively demonstrated that CABG provides superior survival and freedom from repeat revascularization compared to stenting in these high-complexity patient subsets.

Gaf Healthcare connects patients with internationally accredited cardiac surgery programs where experienced teams perform CABG using the latest surgical technologies — including off-pump techniques, minimally invasive approaches, and robotic assistance — and where outcomes data is benchmarked against international quality registries.

What Is CABG? The Anatomy of Bypass Surgery

Coronary artery disease (CAD) develops when cholesterol-rich plaques accumulate inside the coronary arteries — the three main vessels (left anterior descending, left circumflex, and right coronary artery) and their branches that encircle the heart and supply it with blood. As these plaques enlarge, they narrow the arterial lumen, reducing blood flow during exertion (causing angina) and eventually even at rest. If a plaque ruptures, it triggers the formation of a blood clot (thrombus) that can completely occlude the artery within seconds, causing an acute myocardial infarction (heart attack) and irreversible damage to the heart muscle.

CABG does not remove the plaque. Instead, it creates anatomical detours around the blocked segments. The surgeon connects one end of a harvested graft above the blockage (or to the aorta) and the other end below it, creating a new channel for blood flow. For a triple-vessel disease patient, three separate bypasses are created — hence "triple bypass surgery."

The quality and longevity of the bypass depends critically on the type of graft used. The left internal mammary artery (LIMA) — the gold-standard graft — remains patent (open) in over 95% of patients at 10 years and is preferentially used to bypass the left anterior descending artery, the most important coronary vessel. Saphenous vein grafts, while more accessible, have approximately 50% patency at 10 years due to progressive vein graft disease, and are used for additional bypass targets. Bilateral mammary artery grafting and total arterial revascularization have been shown to further improve long-term outcomes in selected patients.

Who Is a Candidate for CABG?

Patient selection for CABG is determined through a multidisciplinary Heart Team evaluation involving cardiologists, cardiac surgeons, and imaging specialists who review the coronary anatomy (from angiography), heart function (from echocardiography), and the overall surgical risk profile of the patient. The SYNTAX score — a standardized anatomical complexity scoring system based on the coronary angiogram — is used to guide the choice between CABG and percutaneous coronary intervention (PCI/stenting).

CABG is strongly recommended for the following patient groups:

Patients with significant left main coronary artery stenosis (≥50% narrowing). The left main artery supplies blood to approximately 70–80% of the left ventricle; its disease is surgical territory.

Patients with three-vessel coronary artery disease (all three main coronary arteries significantly diseased), particularly when left ventricular function is reduced (ejection fraction below 35–40%).

Diabetic patients with multi-vessel disease. The FREEDOM trial demonstrated unequivocally that CABG provides superior survival over stenting in diabetic patients with multi-vessel CAD, largely due to the superior long-term patency of arterial grafts.

Patients who have failed PCI (stent thrombosis or restenosis) or are anatomically not suitable for stenting.

Patients with acute mechanical complications of myocardial infarction (ventricular septal defect, acute mitral regurgitation from papillary muscle rupture).

Conversely, CABG may not be appropriate for patients with very high surgical risk due to multiple comorbidities, severely calcified aorta, poor target vessel quality, or severely reduced pulmonary function. The decision always involves weighing the benefit of complete revascularization against the operative risk.

How CABG Is Performed: Surgical Technique and Approach

The conventional CABG procedure begins with general anesthesia and a median sternotomy — a vertical incision through the sternum (breastbone) that provides access to the heart and great vessels. Simultaneously, a second surgical team harvests the conduit (graft vessel) from the arm or leg. The patient is connected to the cardiopulmonary bypass machine via cannulas in the aorta and venae cavae; the machine oxygenates the blood and circulates it around the body while the surgeon works on the arrested heart.

The heart is stopped using a cold cardioplegia solution that also protects the heart muscle from ischemic injury during the period it is not receiving blood flow. The surgeon then performs each coronary anastomosis under magnification: stitching the graft vessel to the coronary artery below the blockage with fine sutures, creating each bypass channel with precise technical care.

Once all anastomoses are complete, the heart is rewarmed, the cross-clamp is removed, the heart begins beating again, and the patient is weaned off the bypass machine. The sternum is closed with sternal wires, and the skin is closed in layers. The entire procedure typically takes three to six hours depending on the number of bypasses required and the complexity of the coronary anatomy.

The critical quality metrics for CABG include complete revascularization (all significant blockages bypassed), graft quality (confirmed by intraoperative flow measurement or angiography), and preservation of heart function. High-volume cardiac surgery centers publish their outcomes data including 30-day mortality, stroke rate, and deep sternal wound infection rates, which allow meaningful comparison across institutions.

Procedure Steps

1. Pre-operative evaluation: coronary angiography, echocardiography, pulmonary function tests, carotid Doppler, blood work including coagulation profile; surgical risk quantified by EuroSCORE II and STS risk calculator.
2. Anaesthesia and monitoring: general endotracheal anaesthesia; arterial line, central venous catheter, transoesophageal echocardiography (TOE) probe placed for intraoperative cardiac monitoring.
3. Sternotomy: midline sternal incision; pericardium opened and heart exposed; simultaneous conduit harvest (LIMA, radial artery, or saphenous vein).
4. Cardiopulmonary bypass: aortic and venous cannulation; patient placed on bypass; heart arrested with cold cardioplegia solution.
5. Distal coronary anastomoses: each graft sutured to the target coronary artery below its blockage with 7-0 or 8-0 polypropylene sutures under 2.5× to 4.5× magnification.
6. Proximal aortic anastomoses: proximal ends of vein grafts sutured to aorta using partial occlusion clamp; LIMA is left attached to its subclavian artery origin.
7. De-airing and reperfusion: cross-clamp removed; heart reperfused; defibrillation if required; transit-time flow measurement to confirm graft patency.
8. Bypass discontinued; haemostasis achieved; sternal closure with stainless steel wires; patient transferred to cardiac ICU.

Types of CABG Surgery

On-Pump CABG (Conventional)

The most widely performed form of bypass surgery. The heart is stopped and the patient is placed on cardiopulmonary bypass throughout the procedure. Provides a still, bloodless operative field ideal for complex multi-vessel cases and patients with significantly reduced heart function. The gold standard against which all other CABG variants are compared.

Cost: $4,500 – $9,000

Off-Pump CABG (Beating Heart Surgery)

Bypass grafts are sewn onto the beating, contracting heart without stopping it or using a bypass machine. Requires specialized stabilizer devices to immobilize a small section of the heart while the anastomosis is performed. Associated with reduced systemic inflammatory response, lower blood transfusion rates, and potentially fewer neurological complications in high-risk patients. Requires advanced surgical skill.

Cost: $5,500 – $10,000

Minimally Invasive CABG (MIDCAB / MICS CABG)

Bypass performed through small incisions between the ribs (thoracoscopic or direct vision) rather than a full sternotomy. MIDCAB (Minimally Invasive Direct Coronary Artery Bypass) is commonly used for single-vessel disease of the LAD using the LIMA. MICS CABG extends this to multi-vessel disease with specialized retractors and is performed at high-volume minimally invasive cardiac surgery centers. Faster sternal recovery than conventional CABG.

Cost: $7,000 – $14,000

Robotic-Assisted CABG

Uses robotic surgical systems (da Vinci) to harvest the internal mammary artery and perform coronary anastomoses through tiny port incisions. Offers maximal precision and minimal trauma but requires specialized training and equipment. Currently limited to single- or double-vessel disease in selected anatomically suitable patients. Recovery is significantly faster than open CABG.

Cost: $10,000 – $18,000

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $70,000 – $200,000 — Baseline

United Kingdom — $20,000 – $40,000 — ~75% vs. USA

Germany — $18,000 – $35,000 — ~78% vs. USA

India — $4,500 – $9,000 — Up to 93% vs. USA

UAE — $15,000 – $30,000 — ~80% vs. USA

CABG costs vary enormously worldwide, driven by differences in healthcare infrastructure, labor costs, and hospital overhead. In the United States, the total cost of CABG — including the surgical episode, cardiac ICU, and the first post-operative hospital stay — can reach $200,000, making it financially inaccessible for many patients with high deductibles or without comprehensive insurance. Even in the United Kingdom under the NHS, waiting times for elective CABG can extend to several months, during which the patient's clinical status can deteriorate.

At internationally accredited cardiac surgery centers, the same operative quality is delivered at dramatically lower cost — driven not by lower standards but by lower operational and overhead costs. The surgical team's training, the implanted materials (grafts are the patient's own vessels so there is no implant cost differential), the bypass machine technology, and the monitoring standards are identical to those at Western centers.

Gaf Healthcare provides fully itemized, transparent cost estimates for CABG at each partner cardiac center. Packages typically include the surgical team's fees, the cardiac ICU stay, the ward stay, standard medications, and post-operative physiotherapy. The operative risk profile of each patient (EuroSCORE II) is reviewed by the surgical team before an estimate is confirmed.

Recovery & Follow-up

CABG recovery follows a predictable sequence: cardiac ICU for 24–48 hours, cardiac ward for 5–7 days, and then a transition to outpatient rehabilitation. In the ICU, the patient is mechanically ventilated initially; the breathing tube is typically removed within 4–8 hours of surgery (fast-track extubation), and the patient is then breathing independently. Chest drains remove blood and fluid from the operative field and are removed within 24–48 hours once drainage is minimal.

The sternal wound heals over 6–8 weeks as the sternum knits back together. Patients must avoid lifting objects over 5 kg, driving, and pushing/pulling movements for this period to prevent sternal dehiscence. The leg wound from saphenous vein harvest, or the arm wound from radial artery harvest, typically heals faster. Wound care instructions are provided at discharge.

Cardiac rehabilitation — a supervised program of progressive exercise, dietary counselling, and cardiovascular risk factor education — begins 4–6 weeks after surgery and is the single most evidence-based intervention for improving long-term outcomes after CABG. Patients who complete formal cardiac rehabilitation have significantly better 5-year survival rates. Most patients experience a dramatic reduction in angina symptoms and return to work and normal physical activities within 6–12 weeks.

Recovery Tips

• Protect the sternal wound for 6–8 weeks: no lifting over 5 kg, no pulling, no pushing — the sternum must be allowed to unite without stress.
• Walk progressively every day from day one — gentle walking is the single most important rehabilitation exercise in the first weeks.
• Take all prescribed medications including statins, aspirin, beta-blockers, and ACE inhibitors exactly as directed — these reduce the risk of graft failure and future cardiac events.
• Attend every cardiac rehabilitation session — it is the most evidence-based intervention for improving your long-term survival after CABG.
• Control cardiovascular risk factors aggressively: stop smoking immediately and permanently, achieve target blood pressure below 130/80 mmHg, achieve LDL cholesterol below 70 mg/dL.
• Attend all post-operative follow-up appointments including echocardiography at 4–6 weeks to confirm preserved heart function.
• Report immediately any sternal click, separation, redness, or discharge at the sternal wound — these may indicate a wound complication requiring urgent assessment.
• Avoid driving for 4–6 weeks post-operatively — your reaction time and ability to brake safely is impaired during sternal healing.

Risks & Complications

CABG is a major open-heart surgical procedure and carries defined risks that are quantified pre-operatively using validated surgical risk scores (EuroSCORE II, STS PROM). In patients with a normal or low risk profile, 30-day operative mortality at high-volume centers is below 1–2%. Higher risk patients (redo surgery, reduced ejection fraction, severe comorbidities) carry proportionally higher risk.

The most significant specific risks include stroke (1–3% of patients), which can range from temporary neurological changes to permanent deficit. Stroke risk is driven by manipulation of the atherosclerotic aorta and air/plaque embolism during bypass. Deep sternal wound infection (mediastinitis) occurs in approximately 1% of patients and requires prolonged intravenous antibiotics and sometimes surgical wound debridement; diabetic patients and those who receive bilateral mammary artery grafts are at higher risk. Atrial fibrillation develops in 20–30% of patients in the first 72 hours post-operatively and is managed with medication in most cases.

Longer-term risks include graft failure — saphenous vein grafts fail in approximately 40–50% of patients by 10 years due to progressive intimal hyperplasia and atherosclerosis, which is why aggressive statin therapy and aspirin are mandatory post-CABG. Left internal mammary artery grafts have >95% patency at 10 years and are the reason for the excellent long-term outcomes of CABG versus stenting in complex disease.

Why GAF Healthcare

Planning CABG abroad involves more complexity than most medical travel decisions. Gaf Healthcare's cardiac surgery team understands that the pre-operative evaluation — echocardiography, coronary angiography, pulmonary function testing, carotid Doppler — must be completed and reviewed by the operating surgeon before a meaningful cost estimate and surgical date can be confirmed. We facilitate remote digital review of your angiography and echocardiography reports by our partner cardiac surgical teams, so that the planning process begins before you travel.

We partner exclusively with high-volume cardiac surgery programs that publish their outcomes data and are accredited by international quality standards bodies. We do not place patients with centers learning a procedure or where the surgeon's annual case volume is below established safety thresholds. Your cardiac journey with Gaf Healthcare begins with a thorough clinical evaluation and ends only when you are safely home with a clear follow-up plan in place with your local cardiologist.

Frequently Asked Questions

Is CABG safer than stenting for my type of disease?

For triple-vessel disease, left main disease, and diabetic patients with complex multi-vessel disease, the landmark SYNTAX, FREEDOM, and EXCEL trials have shown that CABG provides superior survival and significantly lower rates of repeat revascularization compared to drug-eluting stenting at 5 and 10 years. Your cardiologist and cardiac surgeon will calculate your SYNTAX score from your angiogram to guide this decision objectively.

How long does the bypass graft last?

The left internal mammary artery (LIMA) graft — used to bypass the most important coronary artery — remains patent in over 95% of patients at 10 years and provides exceptional long-term protection. Saphenous vein grafts have approximately 50% patency at 10 years. To maximize graft longevity, aggressive risk factor control (statins, aspirin, blood pressure control) and cardiac rehabilitation are essential.

Can I fly home shortly after bypass surgery?

Most cardiac surgery programs recommend waiting 4–6 weeks before long-haul air travel after CABG. This allows the sternal wound to heal adequately, gives time to confirm stable cardiac function on post-operative echocardiography, and ensures anticoagulation management is stable. Short-haul flights may be permitted earlier in selected low-risk patients. Gaf Healthcare arranges post-operative monitoring and provides a comprehensive medical discharge summary for your home cardiologist.

What happens if a bypass graft fails years later?

Graft failure, particularly of vein grafts, can occur years after surgery. Depending on the clinical presentation (stable angina or acute coronary syndrome) and the anatomy, the options include repeat CABG (redo surgery), coronary stenting of either the native artery or the failing graft, or medical management. Redo CABG carries higher risk than first-time surgery but is feasible at high-volume centers with specialized expertise.

Will I need blood transfusions during CABG?

Blood transfusion rates in CABG have declined significantly with cell-saver technology, meticulous surgical technique, pre-operative optimization of hemoglobin, and off-pump approaches. Many programs now perform CABG with transfusion rates below 20–30% for elective cases. Blood conservation strategies including pre-operative iron supplementation, intraoperative cell salvage, and transfusion trigger optimization are standard at high-quality cardiac centers.

What is the difference between on-pump and off-pump CABG?

On-pump CABG uses a heart-lung bypass machine to support circulation while the heart is stopped and operated on — it provides a completely still operative field, ideal for complex anatomy. Off-pump (beating heart) CABG performs the bypass grafts on the contracting heart without stopping it or using bypass, reducing systemic inflammation and potentially lowering neurological complication rates in high-risk elderly patients. The choice depends on the surgeon's expertise, the patient's anatomy, and cardiovascular risk profile.